These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36920752)

  • 21. Clinical and neuroimaging differences between posterior cortical atrophy and typical amnestic Alzheimer's disease patients at an early disease stage.
    Peng G; Wang J; Feng Z; Liu P; Zhang Y; He F; Chen Z; Zhao K; Luo B
    Sci Rep; 2016 Jul; 6():29372. PubMed ID: 27377199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homonymous Hemianopsia Associated with Probable Alzheimer's Disease.
    Ishiwata A; Kimura K
    J Nippon Med Sch; 2016; 83(2):87-92. PubMed ID: 27180794
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease.
    Jack CR; Wiste HJ; Vemuri P; Weigand SD; Senjem ML; Zeng G; Bernstein MA; Gunter JL; Pankratz VS; Aisen PS; Weiner MW; Petersen RC; Shaw LM; Trojanowski JQ; Knopman DS;
    Brain; 2010 Nov; 133(11):3336-48. PubMed ID: 20935035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Case of Corticobasal Syndrome and Posterior Cortical Atrophy With Biomarkers of Alzheimer Disease.
    Sugimura Y; Baba T; Ezura M; Kikuchi A; Hasegawa T; Nagano I; Suzuki K; Takeda A
    Alzheimer Dis Assoc Disord; 2023 Jul-Sep 01; 37(3):243-245. PubMed ID: 37561961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Whitwell JL; Graff-Radford J; Tosakulwong N; Weigand SD; Machulda MM; Senjem ML; Spychalla AJ; Vemuri P; Jones DT; Drubach DA; Knopman DS; Boeve BF; Ertekin-Taner N; Petersen RC; Lowe VJ; Jack CR; Josephs KA
    Alzheimers Dement; 2018 Aug; 14(8):1005-1014. PubMed ID: 29605222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild cognitive impairment associated with underlying Alzheimer's disease versus Lewy body disease.
    Boeve BF
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S41-4. PubMed ID: 22166451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Progressive Acalculia Presentation of Parietal Variant Alzheimer's Disease.
    Mendez MF; Moheb N; Desarzant RE; Teng EH
    J Alzheimers Dis; 2018; 63(3):941-948. PubMed ID: 29710718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benson's Disease or Posterior Cortical Atrophy, Revisited.
    Yerstein O; Parand L; Liang LJ; Isaac A; Mendez MF
    J Alzheimers Dis; 2021; 82(2):493-502. PubMed ID: 34057092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
    Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
    J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Motor features in posterior cortical atrophy and their imaging correlates.
    Ryan NS; Shakespeare TJ; Lehmann M; Keihaninejad S; Nicholas JM; Leung KK; Fox NC; Crutch SJ
    Neurobiol Aging; 2014 Dec; 35(12):2845-2857. PubMed ID: 25086839
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease.
    Fumagalli GG; Basilico P; Arighi A; Mercurio M; Scarioni M; Carandini T; Colombi A; Pietroboni AM; Sacchi L; Conte G; Scola E; Triulzi F; Scarpini E; Galimberti D
    Neuroimage Clin; 2020; 28():102453. PubMed ID: 33045537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neocortical origin and progression of gray matter atrophy in nonamnestic Alzheimer's disease.
    Phillips JS; Da Re F; Dratch L; Xie SX; Irwin DJ; McMillan CT; Vaishnavi SN; Ferrarese C; Lee EB; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
    Neurobiol Aging; 2018 Mar; 63():75-87. PubMed ID: 29223682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Posterior cortical atrophy. Pathology, diagnosis and treatment of a rare form of dementia].
    Ortner M; Kurz A
    Nervenarzt; 2015 Jul; 86(7):833-9. PubMed ID: 25791802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Ossenkoppele R; Pijnenburg YA; Perry DC; Cohn-Sheehy BI; Scheltens NM; Vogel JW; Kramer JH; van der Vlies AE; La Joie R; Rosen HJ; van der Flier WM; Grinberg LT; Rozemuller AJ; Huang EJ; van Berckel BN; Miller BL; Barkhof F; Jagust WJ; Scheltens P; Seeley WW; Rabinovici GD
    Brain; 2015 Sep; 138(Pt 9):2732-49. PubMed ID: 26141491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease.
    Aziz AL; Giusiano B; Joubert S; Duprat L; Didic M; Gueriot C; Koric L; Boucraut J; Felician O; Ranjeva JP; Guedj E; Ceccaldi M
    Neurobiol Aging; 2017 Jun; 54():22-30. PubMed ID: 28314160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative.
    Veitch DP; Weiner MW; Aisen PS; Beckett LA; Cairns NJ; Green RC; Harvey D; Jack CR; Jagust W; Morris JC; Petersen RC; Saykin AJ; Shaw LM; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2019 Jan; 15(1):106-152. PubMed ID: 30321505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease.
    Lowe VJ; Lundt ES; Albertson SM; Przybelski SA; Senjem ML; Parisi JE; Kantarci K; Boeve B; Jones DT; Knopman D; Jack CR; Dickson DW; Petersen RC; Murray ME
    Alzheimers Dement; 2019 Jul; 15(7):927-939. PubMed ID: 31175025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.
    Schmidtke K; Hüll M; Talazko J
    J Neurol; 2005 Jan; 252(1):27-35. PubMed ID: 15654552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.